These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 14710342)

  • 21. Insulin-like growth factor-I receptor signaling blockade combined with radiation.
    Allen GW; Saba C; Armstrong EA; Huang SM; Benavente S; Ludwig DL; Hicklin DJ; Harari PM
    Cancer Res; 2007 Feb; 67(3):1155-62. PubMed ID: 17283150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness.
    Hsu YM; Chou CY; Chen HH; Lee WY; Chen YF; Lin PW; Alper SL; Ellory JC; Shen MR
    J Cell Physiol; 2007 Mar; 210(3):626-36. PubMed ID: 17133354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
    Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
    Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
    Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF-IR/ERK content and response to IGF-I and insulin in adipocytes from small for gestational age children.
    Iñiguez G; Ormazabal P; López T; Maldonado D; Avila A; Román R; Cassorla F
    Growth Horm IGF Res; 2009 Jun; 19(3):256-61. PubMed ID: 19217812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
    Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
    Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
    Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
    Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
    Surmacz E; Bartucci M
    J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice.
    Moorehead RA; Fata JE; Johnson MB; Khokha R
    Cell Death Differ; 2001 Jan; 8(1):16-29. PubMed ID: 11313699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression.
    Mauro L; Salerno M; Morelli C; Boterberg T; Bracke ME; Surmacz E
    J Cell Physiol; 2003 Feb; 194(2):108-16. PubMed ID: 12494449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.
    Stoeltzing O; Liu W; Fan F; Wagner C; Stengel K; Somcio RJ; Reinmuth N; Parikh AA; Hicklin DJ; Ellis LM
    Cancer Lett; 2007 Dec; 258(2):291-300. PubMed ID: 17950526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.
    Kleer CG; Zhang Y; Pan Q; Merajver SD
    Neoplasia; 2004; 6(2):179-85. PubMed ID: 15140407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.
    Gable KL; Maddux BA; Penaranda C; Zavodovskaya M; Campbell MJ; Lobo M; Robinson L; Schow S; Kerner JA; Goldfine ID; Youngren JF
    Mol Cancer Ther; 2006 Apr; 5(4):1079-86. PubMed ID: 16648580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor.
    Gallagher EJ; Alikhani N; Tobin-Hess A; Blank J; Buffin NJ; Zelenko Z; Tennagels N; Werner U; LeRoith D
    Diabetes; 2013 Oct; 62(10):3553-60. PubMed ID: 23835331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor.
    Yeh S; Hu YC; Wang PH; Xie C; Xu Q; Tsai MY; Dong Z; Wang RS; Lee TH; Chang C
    J Exp Med; 2003 Dec; 198(12):1899-908. PubMed ID: 14676301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Actions of insulin-like growth factor-I on heart].
    Ding YF; He RR
    Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):234-6. PubMed ID: 12545711
    [No Abstract]   [Full Text] [Related]  

  • 40. The type 1 insulin-like growth factor receptor and resistance to DACH1.
    DeAngelis T; Wu K; Pestell R; Baserga R
    Cell Cycle; 2011 Jun; 10(12):1956-9. PubMed ID: 21558809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.